Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CSPG4 may represent prognostic biomarker for chordoma

June 15, 2010

Armodafinil evaluated in healthy subjects and in patients with excessive sleepiness

June 15, 2010

MGMTP140K-modified CD34+ stem cells efficiently engrafted into patients with glioblastoma

June 15, 2010

Cediranib to enter phase II trial in advanced biliary tract cancers

June 14, 2010

ANR-94 is active in rodent models of Parkinson's disease

June 14, 2010

Trials suggest dasatinib or nilotinib could replace imatinib as first-line CML therapy

June 14, 2010

MRX-4 improves several symptoms of grass pollen allergy

June 14, 2010

Dystrophin-based gene therapy evaluated in Duchenne's muscular dystrophy

June 14, 2010

Blood estradiol identified as putative biomarker for testicular mature teratoma

June 11, 2010

Preclinical data support clinical evaluation of apadenoson in sickle cell anemia

June 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...